FDA Medical Device Classification: Class I, II, and III Explained
2026-09-05 · Caduvo Team
FDA medical device classification determines your regulatory pathway, from 510(k) to PMA. Learn how to find your device's product code and what each class means for premarket requirements.
Your device’s FDA class isn’t a label—it’s a gate. The class determines whether you file a 510(k), petition for De Novo, or grind through a PMA. Get it wrong early, and you can burn 18 months and a few hundred thousand dollars on the wrong path.
Classification lives in 21 CFR 862–892. It’s based on the risk the device poses to the patient and the user, not on the technology itself. The FDA assigns a three-letter product code to every device type, and that code ties directly to a regulation number and a class. Find the code, and you instantly know the default premarket submission requirements.
This post walks through the three classes with concrete examples, then shows you exactly how to look up your device’s classification and product code.
The Three Classes: Risk, Controls, and Submission Type
FDA groups devices into Class I, II, or III. As risk increases, so do the regulatory controls and the premarket burden.
- Class I – lowest risk. Most are exempt from premarket notification (510(k)). General controls (registration, labeling, GMPs) apply. Examples: elastic bandages, tongue depressors, examination gloves, dental floss.
- Class II – moderate risk. General controls plus special controls (performance standards, postmarket surveillance, patient registries, guidelines). Most require a 510(k) clearance. Examples: powered wheelchairs, pregnancy test kits, surgical drapes, contact lenses, infusion pumps.
- Class III – highest risk. These sustain or support life, are implanted, or present potential unreasonable risk of illness or injury. They require premarket approval (PMA), which demands clinical data. Examples: implantable pacemakers, heart valves, deep-brain stimulators, silicone breast implants.
About 47% of devices are Class I, 43% Class II, and 10% Class III. But the submission cost difference is stark: a 510(k) might cost $20k–$100k in user fees and testing, while a PMA can exceed $500k in user fees alone, not counting the clinical trial. The 510(k) vs PMA vs De Novo: Choosing Your FDA Pathway deepens that math.
Class I Controls in Practice
Class I devices are exempt from 510(k) unless they fall into a reserved category. Even so, you still must:
- Register your establishment and list the device with FDA.
- Follow Quality System Regulation (21 CFR 820) unless exempted for the specific device type.
- Comply with labeling requirements (21 CFR 801).
Example: A manual toothbrush is Class I, exempt. You can market it without a 510(k) as long as you meet the general controls. But if you add a powered component, it might move to Class II and need a 510(k).
Class II Special Controls
Special controls are device-specific. They can include:
- Mandatory performance standards (e.g., biocompatibility testing per ISO 10993).
- Guidance documents that specify bench testing.
- Patient registries (e.g., joint replacement registries).
Manufacturers of Class II devices must submit a 510(k) demonstrating substantial equivalence to a predicate device. Predicate Devices: Find the Right One for Your 510(k) matters a lot here. If you can’t find a predicate, you may need to use the De Novo pathway.
Class III and the PMA Burden
A PMA is a standalone demonstration of safety and effectiveness, typically requiring a clinical trial. The FDA reviews the manufacturing process, the clinical data, and the proposed labeling. Average total PMA review time is about 200 days, but the clock stops for questions, so real-world timelines often stretch to 12–18 months.
Class III devices automatically get post-approval study requirements, and many must comply with postmarket surveillance (522 studies). The PMA supplement process for any change is also expensive. If your device is truly novel and high risk, plan for at least 3–5 years from concept to approval.
How to Find Your Device Classification and Product Code
FDA organizes everything in the Product Classification Database. You can look up your device by regulation number, device name, or product code. Here’s the step-by-step for a startup evaluating a new idea.
- Go to the FDA Product Classification Database (it’s free).
- Search with a keyword that describes your device’s intended use and technology. “Surgical mesh,” “glucose monitor,” “spinal implant,” etc.
- The results show a three-letter product code, the regulation number (e.g., 21 CFR 878.4320), the device class, and whether it requires a 510(k) or PMA.
- Click the regulation number to read the identification and classification text. That text tells you the exact device type definition—if your device fits, you’ve found your code.
Example: Search “coronary stent.” The database returns product code MAF (Stent, Coronary), regulation 21 CFR 888.4300, Class III, PMA required. You now know the regulatory pathway before you’ve built a prototype.
If you get multiple results, compare the intended use descriptions. A device that measures blood pressure for general wellness is likely Class II (product code DXN), while a device intended to diagnose hypertension is still Class II but with a different code (DXN or DQA). The product code dictates the review division and the guidance documents you’ll need.
What If You Can’t Find a Matching Code?
Sometimes a new device doesn’t fit any existing classification. That’s the De Novo territory. You submit a De Novo classification request to FDA, proposing a risk-based classification (usually Class II) and special controls. If FDA agrees, the device becomes a new device type with its own product code, and you can use that as a predicate for future 510(k) filers. The Breakthrough Device Designation guide explains how that can overlap with De Novo for devices that treat serious conditions.
Why Classification Is the First Step for Reimbursement too
Payers care about FDA class. A PMA-approved device that demonstrates a survival benefit gets a different reimbursement conversation than a 510(k)-cleared Class II device that shows equivalence. CMS often links coverage decisions to the FDA pathway. Many private payers mirror that. Knowing your classification early lets you build the clinical evidence strategy that matches the market access requirements. For the big picture, see Medical Device Reimbursement 101.
Actionable Takeaways
- Look up your product code before you design freeze. It’s the single most important regulatory step you can take in the first week of a project.
- Class I does not mean zero regulation. You still have establishment registration, listing, and QSR unless explicitly exempted.
- If you’re Class II, start collecting predicate device information immediately. The predicate search will define your testing strategy.
- If you’re Class III, start budgeting for the PMA and the clinical trial. Off-the-shelf components won’t save you from the evidence requirement.
- Classification is not static. A change in intended use or a new technological feature can push a device from Class II to Class III. Run the classification search again after any significant design pivot.